Germany
Japan
United Kingdom
China
BID (Myc-DDK-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
Products
View as table Download
Recombinant protein of human BH3 interacting domain death agonist (BID), transcript variant 2
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Special Offer: Get a 20% discount on this product. Use code: "MVPro20".
Lenti ORF particles, BID (Myc-DDK-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
- LentiORF®
-
Lenti ORF particles, BID (mGFP-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
- LentiORF®
-
BID (GFP-tagged) - Human BH3 interacting domain death agonist (BID), transcript variant 2
| Vector | pCMV6-AC-GFP |
| Tag | TurboGFP |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
BID (Myc-DDK-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
BID (GFP-tagged) - Human BH3 interacting domain death agonist (BID), transcript variant 1
| Vector | pCMV6-AC-GFP |
| Tag | TurboGFP |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
BID (Myc-DDK tagged) - Homo sapiens BH3 interacting domain death agonist (BID), transcript variant 4
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
BID (GFP-tagged) - Human BH3 interacting domain death agonist (BID), transcript variant 3
| Vector | pCMV6-AC-GFP |
| Tag | TurboGFP |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
BID (Myc-DDK-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
Lenti ORF clone of Human BH3 interacting domain death agonist (BID), transcript variant 2, Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF particles, BID (Myc-DDK tagged) - Human BH3 interacting domain death agonist (BID), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF clone of Human BH3 interacting domain death agonist (BID), transcript variant 2, mGFP tagged
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF particles, BID (mGFP-tagged) - Human BH3 interacting domain death agonist (BID), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti-ORF clone of BID (Myc-DDK-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 1
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF particles, BID (Myc-DDK-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti-ORF clone of BID (mGFP-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 1
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF particles, BID (mGFP-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti-ORF clone of BID (Myc-DDK-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 3
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF particles, BID (Myc-DDK-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti-ORF clone of BID (mGFP-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 3
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF particles, BID (mGFP-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
BID (Myc-DDK tagged) - Homo sapiens BH3 interacting domain death agonist (BID), transcript variant 5
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
BID (Myc-DDK tagged) - Homo sapiens BH3 interacting domain death agonist (BID), transcript variant 6
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
BID (Myc-DDK tagged) - Homo sapiens BH3 interacting domain death agonist (BID), transcript variant 7
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
BID (GFP-tagged) - Homo sapiens BH3 interacting domain death agonist (BID), transcript variant 5
| Vector | pCMV6-AC-GFP |
| Tag | TurboGFP |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
BID (GFP-tagged) - Homo sapiens BH3 interacting domain death agonist (BID), transcript variant 6
| Vector | pCMV6-AC-GFP |
| Tag | TurboGFP |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
BID (GFP-tagged) - Homo sapiens BH3 interacting domain death agonist (BID), transcript variant 7
| Vector | pCMV6-AC-GFP |
| Tag | TurboGFP |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
BID (GFP-tagged) - Homo sapiens BH3 interacting domain death agonist (BID), transcript variant 4
| Vector | pCMV6-AC-GFP |
| Tag | TurboGFP |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
Lenti-ORF clone of BID (Myc-DDK-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 3
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
BID (untagged)-Human BH3 interacting domain death agonist (BID), transcript variant 1
| Vector | PCMV6-Neo |
| Tag | Tag Free |
| Mammalian Cell Selection | Neomycin |
BID Rabbit Polyclonal Antibody
| Applications | ICC/IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human BID |
Lenti-ORF clone of BID (mGFP-tagged)-Human BH3 interacting domain death agonist (BID), transcript variant 3
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
BID (untagged)-Human BH3 interacting domain death agonist (BID), transcript variant 3
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
BID HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
Transient overexpression lysate of BH3 interacting domain death agonist (BID), transcript variant 2
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
BID (untagged)-Human BH3 interacting domain death agonist (BID), transcript variant 2
| Vector | pCMV6-AC |
| Tag | Tag Free |
| Mammalian Cell Selection | Neomycin |
Recombinant protein of human BH3 interacting domain death agonist (BID), transcript variant 1, full length, with N-terminal HIS tag, expressed in E.Coli, 50ug
| Tag | N-His |
| Expression Host | E. coli |
Goat Polyclonal Antibody against BID
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-TYVRSLARNGMD, from the C Terminus of the protein sequence according to NP_932070.1; NP_001187.1; NP_932071.1. |
Rabbit Polyclonal Bid Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Bid antibody was raised against a peptide corresponding to 14 amino acids near the middle of human Bid. |
Rat Monoclonal anti-BID Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
BID (1-195) human recombinant protein, 0.5 mg
| Expression Host | E. coli |
BID (1-195) human recombinant protein, 0.1 mg
| Expression Host | E. coli |
Active filters
Target Symbol
- BID
Pathways
- Natural killer cell mediated cytotoxicity